Back
Ares Dynamic Credit Allocation Fund Vs. Nektar Therapeutics Industry Stock Comparison
Buy
78
ARDC
Ares Dynamic Credit Allocation Fund
Last Price:
$14.53
Seasonality Move:
-2.72%
Buy
59
NKTR
Nektar Therapeutics
Last Price:
$26.71
Seasonality Move:
4.65%
Buy
78
Ares Dynamic Credit Allocation Fund (ARDC)
is a Buy
Is Ares Dynamic Credit Allocation Fund a Buy, Sell or Hold?
-
The current Ares Dynamic Credit Allocation Fund [ARDC] share price is $14.53. The Score for ARDC is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
-
ARDC is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
59
Nektar Therapeutics (NKTR)
is a Buy
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $26.69. The Score for NKTR is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
NKTR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ARDC Stock Price Chart
What is Ares Dynamic Credit Allocation Fund's stock price today?
-
The Ares Dynamic Credit Allocation Fund share price today is $14.53Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARDC is experiencing slight buying pressure.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $26.69Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing buying pressure, which is a positive indicator for future bullish movement.
ARDC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.06 | Buy |
Relative Strength Index (14 RSI): | 64.14 | Buy |
Chaikin Money Flow: | 24122 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.28 - 14.48) | Buy |
Bollinger Bands (100): | (13.56 - 14.46) | Buy |
NKTR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.83 | Buy |
Relative Strength Index (14 RSI): | 64.5 | Buy |
Chaikin Money Flow: | 602459 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
ARDC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.45 | Buy |
20-day SMA: | 14.36 | Buy |
50-day SMA: | 14.3 | Buy |
200-day SMA: | 14.53 | Buy |
8-day EMA: | 14.47 | Buy |
20-day EMA: | 14.4 | Buy |
50-day EMA: | 14.3 | Buy |
200-day EMA: | 14.37 | Buy |
NKTR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 23.54 | Buy |
20-day SMA: | 23.68 | Buy |
50-day SMA: | 20.5 | Buy |
200-day SMA: | 15.06 | Buy |
8-day EMA: | 24.22 | Buy |
20-day EMA: | 23.51 | Buy |
50-day EMA: | 20.9 | Buy |
200-day EMA: | 16.52 | Buy |
Ares Dynamic Credit Allocation Fund Earnings Growth & ARDC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.01 per share, an increase this year of $2.16 per share, and a decrease next year of $1.84 per share.
Ares Dynamic Credit Allocation Fund Technical Analysis
Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nektar Therapeutics Technical Analysis
Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |